Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Cardiovascular Drugs and Therapy|July 12, 2020
Apixaban Downregulates Endothelial Inflammatory and Prothrombotic Phenotype in an In Vitro Model of Endothelial Dysfunction in UremiaSergi Torramade-Moix, Marta Palomo, Manel Vera, et al.Circulation. Cardiovascular Interventions|August 4, 2017
Impact of Timing on the Functional Recovery Achieved With Platelet Supplementation After Treatment With TicagrelorM Urooj Zafar, Donald A Smith, Usman Baber, et al.Scientific Reports|December 27, 2023
Antithrombotic and prohemorrhagic actions of different concentrations of apixaban in patients exposed to single and dual antiplatelet regimensJulia Martinez-Sanchez, Leticia Castrillo, Didac Jerez, et al.Journal of the American College of Cardiology|February 15, 2020
Ticagrelor With or Without Aspirin After PCI: The TWILIGHT Platelet SubstudyUsman Baber, M Urooj Zafar, George Dangas, et al.American Heart Journal|December 5, 2016
Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT studyUsman Baber, George Dangas, David J Cohen, et al.Cardiovascular Drugs and Therapy|June 15, 2023
Rationale and Design of the SOTA-P-CARDIA Trial (ATRU-V): Sotagliflozin in HFpEF Patients Without DiabetesMaeve Soto Pérez, Jorge Rodríguez-Capitán, Juan Antonio Requena-Ibáñez, et al.Journal of the American College of Cardiology|November 16, 2020
Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection FractionCarlos G Santos-Gallego, Ariana P Vargas-Delgado, Juan Antonio Requena-Ibanez, et al.Pageof 4